OrbiMed and Legend in Musculoskeletal Disease Therapeutics
16 Dec 2024
US$ 19.00
OrbiMed Advisors LLC, Legend Capital, 3H Health Investment have participated in the US$120 million series C ......
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 20 Dec 2024)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.